Alert fatigue is related to the barrage of messages provided clinical decision support systems which can overwhelm a provider and cause them to ignore messages. The alerts, while found to be helpful in some cases, can result in a type of "fatigue" whereby the provider, after receiving too many alerts, begins to ignore and/or override the alerts. Receiving too many alerts can result in slowing the provider down rendering the alert useless.
One of the key reasons that clinicians are frustrated with decision support related to drug interaction software is the potential for this alert fatigue. Clinicans do not want to be messaged regarding dosage precautions related to an interaction which has already been recognized and addressed. It is particularly important in the era of electronic prescribing to engineer systems which can present the appropriate information to the appropriate person. Systems need to recognize whether an individual has previously addressed the issue, rather than simply blindly alerting to the presence of two medications within the medicine list. A collaborative effort between drug database providers and application vendors is needed, and discussions to improve the quality of alerts, while decreasing the quantity, are moving forward. These will greatly improve satisfaction with these tools.
Not all clinical information is structured the same!
The more detail that your medication and clinical information vendor provides about crucial alerts, the easier it is for you to implement customization for your users. If every alert looks the same (which is true of what many vendors provide!), then that means that your users will have to go through them all one by one, setting their preferences on warnings and dosage precautions by hand. Then they have to keep their settings up to date as new alerts are added. That's not user friendly design!
By contrast, Lexicomp's implementation of Black Box Warnings (also called Black Boxed Warnings) gives a great deal of flexibility to developers to allow for multi-dimensional customization. Each warning contains information about which clinician the alert is intended for, how severe the alert is, and whether the alert applies only to patients with specific conditions (e.g., pregnancy).
Win customer loyalty by automating alert customization!
This way, you can automate much of the customization without having to ask for input from every individual user. You can simply have the system hide alerts intended for nurses from pharmacists, and vice-versa. Likewise, you can make your system intelligent enough to hide alerts related to pregnancy from male patients. This is the kind of smart implementation that users are looking for to help them aviod alert fatigue and become more efficient and effective clinicians. Talk to Lexicomp today to learn more!
Medication errors and adverse drug events are serious issues in healthcare. Apprx 770,000 injuries or deaths related occur each year. For this reason and to comply with the certification and meaningful use requirements, every EMR should look at partnering with and providing their customers top rated drug interaction, duplicate therapy, allergy and dose range checking information integrated into their EMR. Lexicomp and Lexi-Data can offer this solution.
This information and its quality, customizability, and delivery format can really set your EMR apart from the competition. In 2010 the EMR market grew by almost 13.5% while competition in this area is also growing at a higher than predicted rate. More and more physicians are now starting to look at implementation of an EMR although the rate of adoption has been slowed by the complicated maze of meaningful use. None the less, it is critical that EMRs differentiate and help physicians understand how to navigate through this maze. Drug Data Vendors that are able to offer what others may not can help these EMR companies win more deals. Drug interactions that are cusomizable, dose range checking for specific populations (adult, pediatric, geriatric) duplicate therapy checking and an overall solid patient education offering are areas that can be easily implemeted from Lexi-Data. Lexicomp's expertise and customer service can also help get you up and running fast. The database is easy to work with, available in mutliple formats and even has a web-service set can help start up and established EMRs build the structure needed to help physicians.
For more information visit www.lexi.com/businesses/ehr-vendors/
For years, Multum Lexicon was the source for researchers to get drug reference and drug interaction data. But where can researchers now get medication lists, pharmaceutical monographs, drug-drug interactions, drug-allery interactions, and more?
Today, there is an enhanced and updated solution built on the foundation of Multum Lexicon. It's Lexicomp's Lexi-Data transactional database. Lexi-Data provides drug names (brand name, generic name, and common abbreviations), therapeutic categories, drug classifications, indications, and standard coding such as NDC, J-Codes, and ICD-9. The data in Lexi-Data has been utilized by many universities and research institutions, including research on pharmaceutical policy and outcomes, aging, and more.
Multum is a registered trademark of Cerner Corp.
Patients are becoming more involved in their own healthcare, and are increasingly making use of patient portals and consumer-facing websites to do research, follow their progress, and even answer questions they might have previously posed to their physician. At the very least, they are using these sites to be more informed during visits to their care providers so they can get more value from those encounters.
All of this creates an opportunity for innovative developers to provide accurate, reliable, easy-to-understand information to patients via the web. One source for medication and clinical information that can be easily integrated into such sites is Lexicomp.
Lexicomp is a leading provider of drug reference, clinical reference, and patient education leaflets and materials to clinicians. Over a thousand hospitals use Lexicomp's information every day during patient encounters. The information available includes medication lists, drug monographs, drug interaction information (including interactions with common food and natural products), drug allergy information, patient education documents, dose adminstration, warnings, and more.
And Lexicomp's information can be easily integrated into your site in a variety of ways. You can choose to have an installed local database, or to use web services to pull information from Lexicomp's servers as needed. Contact Lexicomp today to find out how to populate your patient portal or consumer website with the information your users are looking for.
When developing an EHR system, when is the right time to evaluate a drug interaction database? Because there are only a handful of vendors in the market, it makes sense to evaluate their respective offerings several times. Certainly, before you make the final decision to go with any particular vendor, you should talk once more to the other data providers to ensure nothing has changed.
A lot can change in a few months
One vendor that has added a lot of enhancements to their medication and clinical information is Lexicomp. Evaluating their solution today versus a year ago would show many differences in capabilities.
Some of the new enhancements include:
In an industry like this where things can change quickly but in which product development can sometimes span years, it's important to check in with possible vendors more than once! If you haven't talked to Lexicomp recently, click the links on this page to set up a conversation with them now.
One of the most common comments I hear from users of Electronic Medical Records (EMR) systems is associated with “alert fatigue” from unwelcome drug interaction notifications. Many users tell me that they are flooded with unavoidable but unnecessary alerts that interrupt their workflow, decrease productivity, and make the important alerts harder to see. Clinicians find themselves clicking through the alerts as quickly as possible which defeats the purpose of clinical decision support.
In today's fast-paced healthcare industry, electronic health record (EHR) and other healthcare information system vendors need smart, current drug data that will enable their systems to drive patient safety and improve healthcare -- without generating a flood of annoying alerts that will only be ignored. Lexicomp has recently included new functionality that can alert users with the appropriate Black Box Warning where appropriate in the current workflow.
In the most simple terms, an FDA Black Box Warning is the strongest warning that the US Food and Drug Administration (FDA) puts on a drug. It means that you should pay close attention to the drug's usage because there are some potentially extremely harmful or dangerous threats to your health that the already FDA approved drugs could pose.
The other side of the coin, however, is that an FDA Black Box Warning means that despite the FDA's knowledge of these harmful, serious and sometimes deadly side effects that they are still leaving the FDA approved drug on the market for you to be able to take and potentially experience these harmful side effects. In theory, these FDA Black Box Warnings are designed for both the doctor who is prescribing the drug to be aware of the problems and for you as the consumer to be more aware.
The warning is placed in a prominent 'black box' on the package insert of an FDA approved drug so that people and their doctors can be more aware of it, but few doctors ever see the pill bottles and the vast majority of consumers realistically aren't going to go through the amazingly large amount of technical and medically detailed information on a package insert. This can lead to doctors note being aware of a serious alert which can have serious consequences. With Lexicomp’s inclusions of Black Box Warnings within their medication database, the warnings can be provided to the physician during the prescription process where they are most needed.
There are many universities and institutions that now require access to an up-to-date standardized drug database which would be used for analytics, claims review / auditing, or research purposes. Many of these universities and/or institutions now have a Pharmaceutical Outcomes and Policy department or Institute on Aging department that are focused on various aspects of research.
One solution that has long served the needs of these researchers and univerisities is Multum's Lexicon. Another is Lexi-Data Basic.
Lexi-Data Basic provides drug information that includes drug names (brand name, generic name, and common abbreviations), therapeutic categories, drug classifications, indications, and standard coding such as NDC, J-Cods, and ICD-9. Lexi-Data Basic is powered by the widely known and trusted Multum Lexicon which has been utilized by hundreds of universities and institutions in the past. Multum is a registered trademark of Cerner Corp.
For more information on Lexi-Data Basic, click the links to fill out the form on this page.
Having a sick child can be a challenging and stressful time for any parent. A sick child also presents challenges for health care professionals as well as health information systems as it relates to prescribing medications. For a number of medications, pediatric dosage calculations are based on weight. Having a weight available in the community pharmacy setting is often challenging, however this is only the first step in being able to validate the correct dosage range. The second piece necessary to accurately check the validity of a pediatric prescription is having the correct information in your pharmacy system.
All too often, community pharmacy systems are not equipped with the necessary drug reference database to accurately evaluate a pediatric dose. For over 15 years, pediatric practitioners have been using Lexicomp's Pediatric Dosage Handbook and more recently, our electronic versions to prescribe and validate pediatric dosing. Now, this information has been transformed into a data set that can be integrated into pharmacy systems to allow your HIS to help you validate these critical doses. For more information, visit http://www.lexi.com/businesses/ehr-vendors/.
As it is part of Meaningful Use Stage 1, drug interaction checking is a critical piece. Not only is it required for reimbursement, but it is also important for improving patient safety. The difference between content and the quality and depth of the interaction information that you choose to integrate is important to understand. Many common drug references have an interaction checker where you can manually enter the medications a patient is taking and check for the significance of any interactions. For clinicians and patient safety this is important; however, when it resides outside of the workflow it can become time consuming.
A drug interaction list within your system can increase the likelihood that interactions will be checked as it puts these alerts directly into the workflow. Some of the most important aspects are not the common drug interactions, but the uncommon interactions that are not widely known. Keep in mind that users of your system will most likely want to customize or localize alerts to cut down on the number of insignificant alerts to reduce alert fatigue. Lexi-Data can help with this as the database is structured to allow for customization, turning off of certain alerts, and is an overall robust interaction checker covering common and less common drug interactions. Lexi-data also allows for drug interaction checking via a web service so there is less IT development time and maintenance. Contact Lexicomp to request more information on drug interaction lists.